MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)

• Status: Completed
• Trial end date: 2003-10-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the efficacy of MK0524 on seasonal allergies.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.

Criteria

Inclusion Criteria:

• Person has had at least 2 years of seasonal allergies

• Person has had a positive skin test to at least 1 of the allergens of the season

• Person is a non-smoker

Exclusion Criteria:

• Person has been hospitalized within the last 4 weeks

• Person is a female who has had a baby within the last 8 weeks or is still breast-feeding